N-[(3-chloro-6-fluoro-1H-indol-5-yl)methyl]-2-[(6-fluoroquinolin-3-yl)methyl]pyridine-4-carboxamide
C25H17ClF2N4O — CID 118212861
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3-chloro-6-fluoro-1H-indol-5-yl)methyl]-2-[(6-fluoroquinolin-3-yl)methyl]pyridine-4-carboxamide
N-[(3-chloro-6-fluoro-1H-indol-5-yl)methyl]-2-[(6-fluoroquinolin-3-yl)methyl]pyridine-4-carboxamide (PubChem CID 118212861) has the molecular formula C25H17ClF2N4O and a molecular weight of 462.89 g/mol. Its IUPAC name is N-[(3-chloro-6-fluoro-1H-indol-5-yl)methyl]-2-[(6-fluoroquinolin-3-yl)methyl]pyridine-4-carboxamide.
Molecular Properties
| Compound Name | N-[(3-chloro-6-fluoro-1H-indol-5-yl)methyl]-2-[(6-fluoroquinolin-3-yl)methyl]pyridine-4-carboxamide |
|---|---|
| PubChem CID | 118212861 |
| Molecular Formula | C25H17ClF2N4O |
| Molecular Weight | 462.89 g/mol |
| Exact Mass | 462.11 |
| IUPAC Name | N-[(3-chloro-6-fluoro-1H-indol-5-yl)methyl]-2-[(6-fluoroquinolin-3-yl)methyl]pyridine-4-carboxamide |
| SMILES | O=C(NCc1cc2c(Cl)c[nH]c2cc1F)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1 |
| InChI | InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(9-20(21)24)12-32-25(33)15-3-4-29-19(8-15)6-14-5-16-7-18(27)1-2-23(16)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33) |
| InChIKey | PDPRSJXGOZQXDE-UHFFFAOYSA-N |
| XLogP | 5.56 |
| TPSA | 70.67 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.89 |
| LogP ≤ 5 | 5.56 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118212861 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.